PREventative Study Against URate-lowering Drug-induced Gout Exacerbations 1 (PRE-SURGE1)
This study has been completed.
Information provided by (Responsible Party):
First received: January 23, 2009
Last updated: April 26, 2012
Last verified: April 2012
No Study Results Posted on ClinicalTrials.gov for this Study
|Study Status:||This study has been completed.|
|Study Completion Date:||June 2010|
|Primary Completion Date:||May 2010 (Final data collection date for primary outcome measure)|
|Certification or Request for Extension to Delay Results Received:||January 5, 2011|
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Schumacher HR Jr, Evans RR, Saag KG, Clower J, Jennings W, Weinstein SP, Yancopoulos GD, Wang J, Terkeltaub R. Rilonacept (interleukin-1 trap) for prevention of gout flares during initiation of uric acid-lowering therapy: results from a phase III randomized, double-blind, placebo-controlled, confirmatory efficacy study. Arthritis Care Res (Hoboken). 2012 Oct;64(10):1462-70. doi: 10.1002/acr.21690.